User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: May 01 2016 06:41 IST RSS 2.0
 
1 to 20 of 2,712    
How Sami Group's Muhammed Majeed is eyeing large-scale cultivation of monk fruit to stall our sugar obsession 1.5.2016 ET: Food
Muhammed Majeed is eyeing cultivation of the monk fruit in India, a zero-calorie, natural sugar substitute that might be the answer to our sugar obsession.
Also found in: [+]
'US Trade watch list threatens access to life-saving drugs' 28.4.2016 TOI: India Business
Many US industries, in particular the pharmaceutical industry, use the report to condemn and pressure governments which employ IP systems that do not match US intellectual property laws and practices.
Also found in: [+]
India won't succumb to any pressure on IPR issues: Nirmala Sitharaman 26.4.2016 ET: Policy
Sitharaman said that India is working on a case based on the fact that several states in the US are also possibly giving a domestic content like benefit to their companies.
Also found in: [+]
'Patent your innovations, claim authority' 23.4.2016 TOI: India
Also found in: [+]
Roche sues Intas Pharma over Mircera anaemia drug patent 18.4.2016 ET: Pharma
Swiss biotechnology giant Roche has sued Ahmedabad-based drug maker Intas Pharmaceuticals in Delhi High Court, alleging infringement of its patent rights over Mircera.
Also found in: [+]
Two generics makers end battle to copy drugs amid patent debate 12.4.2016 ET: Pharma
Both companies, BDR Pharma and Lee Pharma, had been seeking so-called compulsory licenses that override patents and allow generics firms in India to launch cheap copies of medicines
Also found in: [+]
Pfizer may leverage European approval to pneumonia vaccine in Indian market 7.4.2016 ET: Pharma
New York-headquartered pharmaceutical giant is likely to leverage its latest European approval for multi-dose vials of pneumococcal vaccine Prevnar 13 in the Indian market.
Also found in: [+]
CSIR Features in the Thomson Reuters Top 50 Indian Innovator Companies and Research Organizations for the Year 2015 6.4.2016 Govt of india: PIB
The Council of Scientific and Industrial Research (CSIR) features in the Thomson Reuters top 50 Indian Innovator companies and research organizations for the year 2015. The Top 50 Indian Innovators lead the country in innovation output. They are a group of businesses and research institutions that
Also found in: [+]
NHRC seeks report from government on its stand on generic medicines 2.4.2016 ET: Pharma
The Commission has called for reports on the matter within two weeks from the secretaries of the commerce and health ministries, according to the human rights body.
Also found in: [+]
NHRC seeks report from govt on its stand on generic medicines 1.4.2016 TOI: Cities
New Delhi, Apr 1 () The National Human Rights Commission (NHRC) has sought a report from Ministries of Commerce and Health on media reports that the government has restrained production of cheaper versions of generic ...
Also found in: [+]
Insight: Drug shortages prompt question: are some medicines too cheap? 1.4.2016 Sify Finance
By Ben Hirschler
Also found in: [+]
GE, Boeing, Honeywell back India on patents 26.3.2016 Rediff: Business
India's IPR framework and enforcement were comparable to those in developed countries
Also found in: [+]
Government won't dilute stance to waive patent rights 24.3.2016 ET: Policy
The government has ruled out any dilution in its stance on granting compulsory licences, or waiving patent rights in case of a public health emergency.
Also found in: [+]
Govt won't dilute stance to waive patent rights 24.3.2016 TOI: India Business
Also found in: [+]
Government defends right to issue drug ‘compulsory licences’ 23.3.2016 TOI: India Business
The government has defended its right to grant licences allowing local companies to override patents and make cheaper copies of drugs discovered by big western drugmakers, and said reports to the contrary were "factually incorrect".
Also found in: [+]
India defends right to issue drug 'compulsory licences' 23.3.2016 Rediff: Business
The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.
Also found in: [+]
India defends right to issue drug "compulsory licences" 23.3.2016 Sify Finance
MUMBAI, March 23 (Reuters) - India has defended its right to grant licences allowing local firms to override patents and make cheaper copies of drugs discovered by big Western drugmakers, and said
Also found in: [+]
India has right to grant compulsory licences under WTO: Govt 22.3.2016 TOI: Cities
New Delhi, Mar 22 () The government today said every member of the WTO, including India, has the right to grant compulsory licences (CL) and also decide the grounds for issuing ...
Also found in: [+]
Doctors Without Borders challenges Pfizer's vaccine patent application in India 12.3.2016 ET: Pharma
Not-for-profit medical charity Doctors Without Borders (MSF) has challenged a patent application of US drug major Pfizer in India for its pneumonia vaccine.
Also found in: [+]
MSF challenges Pfizer's India vaccine patent application 12.3.2016 ET: Pharma
The medical aid group has challenged Pfizer's patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine.
Also found in: [+]
1 to 20 of 2,712